OpenAlex
PricingAboutJobs
Log inGet started
Work

Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors

HTML

Year: 2023
Type: article
Source: Endocrine Related Cancer
DOI: 10.1530/erc-22-0269
Authors: Tommaso Porcelli, Raffaele Ambrosio, Maria Angela De Stefano, Cristina Luongo, Daniela Terracciano, Caterina Miro, Monica Dentice, Martin Schlumberger, Domenico Salvatore
Institutions: Federico II University Hospital, University of Naples Federico II, Université Paris-Saclay, Institut Gustave Roussy, CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)
Language: English

Topic: Thyroid Disorders and Treatments
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: vandetanib, type 2 deiodinase, tyrosine kinase inhibitors, thyroid hormone metabolism, hypothyroidism, fibro-adipogenic progenitors, selenoenzymes, type 3 deiodinase, type I deiodinase, drug-induced thyroid dysfunction
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4317867331
FWCI: 1.202
Cites: 41
Cited by: 8
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security